Stay updated on CB-839 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the CB-839 in Solid Tumors Clinical Trial page.

Latest updates to the CB-839 in Solid Tumors Clinical Trial page
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedUpdate includes a critical operating-status notice and a new software version (v3.2.0), indicating updated deployment; removal of the prior version tag (v3.1.0) accompanies the upgrade.SummaryDifference4%
- Check24 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%
- Check38 days agoChange DetectedThis is a minor release update: Revision changed from v3.0.1 to v3.0.2, and the Back to Top control was removed. No significant core content or critical data (pricing, time slots) appear to have changed.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check52 days agoChange DetectedThe web page has added significant information regarding various diseases and drug information, including details on Cannabidiol and several types of carcinomas, while removing some previously listed genetic resources and neoplasms.SummaryDifference11%
- Check60 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.7%
Stay in the know with updates to CB-839 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CB-839 in Solid Tumors Clinical Trial page.